Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
22.12
-0.15 (-0.67%)
At close: Oct 28, 2025, 4:00 PM EDT
22.35
+0.23 (1.03%)
After-hours: Oct 28, 2025, 7:42 PM EDT
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 7 analysts that cover Elanco Animal Health stock have a consensus rating of "Buy" and an average price target of $20, which forecasts a -9.58% decrease in the stock price over the next year. The lowest target is $13 and the highest is $25.
Price Target: $20 (-9.58%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 3 | 3 | 3 | 4 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +13.02% | Oct 20, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $18 → $24 | Hold → Buy | Upgrades | $18 → $24 | +8.50% | Oct 7, 2025 |
| Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +3.98% | Sep 24, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $18 | Hold | Maintains | $12 → $18 | -18.63% | Aug 11, 2025 |
| UBS | UBS | Strong Buy Maintains $18 → $19 | Strong Buy | Maintains | $18 → $19 | -14.10% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
4.70B
from 4.44B
Increased by 5.77%
Revenue Next Year
4.93B
from 4.70B
Increased by 4.96%
EPS This Year
0.92
from 0.68
Increased by 35.51%
EPS Next Year
1.02
from 0.92
Increased by 11.08%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9B | 5.1B | |||
| Avg | 4.7B | 4.9B | |||
| Low | 4.5B | 4.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.5% | 9.6% | |||
| Avg | 5.8% | 5.0% | |||
| Low | 1.0% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.05 | 1.10 | |||
| Avg | 0.92 | 1.02 | |||
| Low | 0.84 | 0.94 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 54.4% | 19.6% | |||
| Avg | 35.5% | 11.1% | |||
| Low | 23.9% | 2.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.